MétaCan
Menu
Back to cohort
Record W4390606967 · doi:10.21203/rs.3.rs-3829844/v1

Adaptive designs in clinical trials: a systematic review-part I

2024· preprint· en· W4390606967 on OpenAlexafffund
Mohamed Ben‐Eltriki, Aisha Rafiq, Arun Paul, Devashree Prabhu, Michael Afolabi, Robert Bashaw, Christine Neilson, Salaheddin M. Mahmud, Thierry Lacaze‐Masmonteil, Susan Marlin, Martin Offringa, Nancy J. Butcher, Anna Heath, S. Michelle Driedger, Lauren E. Kelly

Bibliographic record

VenueResearch Square · 2024
Typepreprint
Languageen
FieldMathematics
TopicStatistical Methods in Clinical Trials
Canadian institutionsHospital for Sick ChildrenSickKids FoundationGeorge & Fay Yee Centre for Healthcare InnovationUniversity of TorontoRobarts Clinical TrialsInstitute for Clinical Evaluative SciencesUniversity of CalgaryUniversity of Manitoba
FundersCanadian Institutes of Health ResearchSeqirusResearch ManitobaNatural Sciences and Engineering Research Council of CanadaGlaxoSmithKline
KeywordsClinical trialPsychological interventionMEDLINEMedicineClinical study designSystematic reviewAlternative medicineAdaptive designResearch designMedical physicsPathologyPsychiatry

Abstract

fetched live from OpenAlex

Abstract Background: Adaptive designs (ADs) are intended to make clinical trials more flexible, offering efficient and potentially cost-saving benefits. Despite a large number of methods-based research papers in the literature on different adaptations to trials, the advantages and limitations of such designs remain unfamiliar to large parts of the clinical community including those in pediatric medicine where efficient clinical trials are essential to inform care. This systematic review provides an overview of the use of ADs in published clinical trials (Part I) and compares the application of AD in trials in adult and pediatric studies, providing real-world examples and recommendations for the child health community (Part II). Methods: Published studies from 2010 to April 2020 were searched in the following databases: MEDLINE (Ovid), Embase (Ovid), and International Pharmaceutical Abstracts (Ovid). Protocols, reports, and a secondary analysis using AD were included. We did not include any trial registrations and interventions other than drugs or vaccines. Data from the published literature on study characteristics, types of adaptations, statistical analysis, stopping boundaries, logistical challenges, operational considerations and ethical considerations were extracted and summarized herein. Results : Out of 23,886 retrieved studies, 317 publications of adaptive trials, 267 (84.2%) trial reports, and 50 (15.8%) study protocols), were included. Most trials included only adult participants (265, 83.9%), 16 trials (5.4%) were limited to only children and 28 (8.9%) were for both children and adults. Dose finding designs were used in the highest proportion of the included AD (82, 22.4 %), followed by adaptive randomization (56, 14.4%), group sequential design in 47 trials (12.8%), then drop-the-losers (pick-the-winner) design in 28 trials (7.6%) and seamless phase 2-3 design in 27 trials (7.4%). Approximately 203 (64%) studies used frequentist statistical methods and 75 (23.7%) used Bayesian methods. Conclusion: In Part I of this review, we provide a comprehensive overview of the landscape and methodological features of adaptive clinical trials. We found that adaptive designs were applied mostly in Phase II oncology trials, aimed to establish efficacy and determine the choice of doses for the Phase III of the trials. Phase I trials of new drugs that included adaptations most frequently aimed to identify the maximum tolerable dose. Adaptation details were not uniformly reported across all trials and were hardly reported in the pediatric trials. Study protocol registration: DOI:10.1186/s13063-018-2934-7

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.462
metaresearch head score (Gemma)0.932
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Meta-epidemiology (narrow), Research integrity, Insufficient payload (model declined to judge)
Consensus categoriesMetaresearch, Research integrity, Insufficient payload (model declined to judge)
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.703
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.4620.932
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0100.002
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0020.004
Research integrity0.0020.012
Insufficient payload (model declined to judge)0.0010.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.960
GPT teacher head0.773
Teacher spread0.187 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designSystematic review
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueResearch SquareSame topicStatistical Methods in Clinical TrialsFrench-language works237,207